Aim Bulletin
Frontier IP's TVG appoints advisory board for herpesvirus vaccine
Intellectual property commercialisation specialist Frontier IP Group announced on Wednesday that its portfolio company, The Vaccine Group (TVG), had appointed an advisory board to facilitate the expansion of its herpesvirus-based vaccine platform.
Ondine raises $3.6m to help commercialise Steriwave
Life sciences company Ondine Biomedical has successfully raised CAD 4. 91m ($3. 62m), it announced on Wednesday, bolstering its efforts to commercialise its photodisinfection technology aimed at reducing healthcare-associated infections (HAIs).
Good Energy's Zapmap expands to mainland Europe
Good Energy announced on Wednesday that its EV charging point mapping subsidiary Zapmap had introduced charge point mapping services in mainland Europe.
Tekcapital investee Lucyd integrates ChatGPT into app
Intellectual property investor Tekcapital updated the market on its portfolio company Innovative Eyewear on Wednesday after the latter unveiled a significant update to the Lucyd app for Android.
Creo launches 'Speedboat Ultraslim' with first UK procedure
Creo Medical Group announced a significant milestone for its Speedboat UltraSlim medical device in the field of surgical endoscopy on Wednesday.
Wishbone confirms visual results from Cottesloe drilling
Wishbone Gold updated the market on its ongoing diamond drill programme on Wednesday at the Cottesloe project in the Paterson Range of Western Australia.
Bushveld gives notice to 40pc of head office staff
Vanadium producer Bushveld Minerals said in an update on Wednesday that it was implementing strategic cost-cutting measures to ensure long-term competitiveness and financial stability, while also right-sizing its head office staff to align with a renewed focus on core operational assets.
Seeing Machines upbeat on proposed US driver safety rules
Driver monitoring technology specialist Seeing Machines updated the market on Wednesday, on an announcement from the US National Highway Traffic Safety Administration (NHTSA).
Hutchmed completes trial enrolment, keeps drugs on China funding list
Hutchmed China announced a significant milestone in its clinical trials on Wednesday, as well as the inclusion of two of its drugs on the National Reimbursement Drug List (NRDL) in China.
Greatland Gold unveils results of drilling at Scallywag
Greatland Gold announced the results of its 2023 drilling and geophysical exploration programme at its wholly-owned Scallywag tenement in the Paterson Region of Western Australia on Wednesday, next to its flagship Havieron gold-copper project.
Springfield Properties H1 trading in line with internal expectations
Scottish housebuilder Springfield Properties said on Wednesday that trading in the first half had been in line with management expectations, setting the group on a course to meet its debt reduction targets.
HVivo jumps on contract win, guidance upgrade
Shares in AIM-listed HVivo jumped on Wednesday morning after the clinical trials and laboratory services group won a new £17m contract and announced it was trading ahead of guidance.
Avacta hails "encouraging" clinical data from cancer-targeting study
Oncology drugs group Avacta has announced positive results from its lead pre|CISION™ programme, AVA6000, which it says has the potential to be "truly remarkable".